Tag: 2021 earnings
Rubius Therapeutics reports $196.5M loss in 2021
PROVIDENCE – Rubius Therapeutics Inc. on Friday reported a loss of $196.5 million in 2021, or $2.23 per diluted share.
The clinical-stage biopharmaceutical company, which...
Providence Journal parent company posts $135M loss in 2021
PROVIDENCE – Gannett Co., parent company of The Providence Journal, on Thursday reported a year-end loss that narrowed to $135 million in 2021, or...










